The best continuous glucose monitors (CGMs) of 2025 are the Dexcom G7 (15-day version) and the Abbott FreeStyle Libre 3, offering top-tier accuracy, real-time tracking, and seamless integration with mobile apps and insulin delivery systems. These devices stand out for their reliability, extended wear time, and user-friendly features, making them ideal for individuals managing type 1 or type 2 diabetes with or without insulin therapy.
The article also explains how CGMs work, with small sensors that track glucose through the skin in real time. It covers emerging wellness devices for non-diabetics, offers a comparison of who each CGM is best for, shares user feedback, and clarifies the difference between clinical and consumer use.
A Continuous Glucose Monitor (CGM) is a medical device that provides real-time glucose readings without the need for traditional fingerstick tests. This innovative system consists of three main parts that work together to give you a complete picture of your glucose levels.
CGMs provide a more complete picture of glucose fluctuations throughout the day and night, allowing users to see how food, exercise, stress, and medication impact their blood sugar.
Here are the top continuous glucose monitors (CGMs) of 2025, selected based on accuracy, wear time, ease of use, and integration with other health systems. Whether you’re managing diabetes or tracking wellness trends, these devices offer cutting-edge tools for real-time glucose monitoring and better health decisions.
Now FDA-cleared for 15-day wear, the Dexcom G7 delivers high accuracy and best-in-class predictive alerts. It integrates easily with smart devices and insulin pumps, making it a favorite for tech-savvy diabetics needing tight glucose control.
The Libre 3 offers accurate, continuous glucose readings with a compact sensor that lasts up to 14–15 days. It provides automatic updates to your smartphone every minute, making it convenient for both type 1 and type 2 diabetes users.
Eversense offers the longest-lasting CGMs on the market, with sensors that last up to 180 days or even one year with the Eversense 365. These implantable sensors come with a removable transmitter and provide real-time alerts via subtle vibrations.
Guardian 3 works closely with Medtronic’s insulin pumps and uses SmartGuard technology for predictive alerts. Simplera Sync, expected later in 2025, will eliminate fingersticks and bring streamlined integration to the MiniMed 780G system.
Dexcom Stelo is a non-prescription CGM designed for wellness users rather than diabetics. Based on G7 tech, it provides real-time glucose trends without medical alerts, ideal for fitness and metabolic tracking.
Aimed at general health users, Lingo simplifies glucose monitoring with an easy-to-understand "Lingo count." While it lacks clinical-grade precision, it's affordable, app-based, and great for those exploring blood sugar trends without medical needs.
These top CGMs of 2025 serve a wide range of users—from those needing precise diabetes management to people seeking better insight into their metabolic health. Choosing the right device depends on your goals, whether clinical control or wellness awareness.
For those without diabetes but interested in understanding how food, exercise, stress, or sleep affect their blood sugar, consumer and wellness-focused CGMs offer a new way to gain metabolic insight. These devices are typically available without a prescription and are designed for people with pre-diabetes, health goals, or a general interest in optimizing well-being.
Dexcom Stelo is an over-the-counter CGM based on the trusted G7 platform, designed specifically for non-insulin users. It tracks real-time glucose data but does not include medical alerts, making it ideal for those focused on nutrition, fitness, and metabolic trends.
Ready to try Dexcom Stelo?
You can order it directly through our store. Just click below to view details, check availability, and add it to your cart.
Lingo is a wellness-focused CGM that offers simplified glucose tracking through its "Lingo count" system, helping users understand how their body responds to meals and activity. While not medically calibrated for diabetes, it's an affordable and user-friendly tool for general metabolic awareness.
These platforms combine CGM data with personalized coaching, AI analysis, and lifestyle recommendations. Aimed at health-conscious users, they help optimize energy, weight, and performance by analyzing glucose response to meals, exercise, and fasting routines.
Still emerging, Biolinq uses a non-invasive microneedle patch to track glucose painlessly. While not as accurate as prescription CGMs, it’s promising for users seeking a needle-free, long-wear option to monitor trends over time.
These wellness CGMs empower users to take control of their health through personalized glucose insights. While not intended to replace clinical tools for diabetes care, they offer valuable guidance for anyone aiming to improve energy, performance, or metabolic flexibility.
Choosing the right continuous glucose monitor (CGM) depends on your health goals, whether you're managing diabetes, monitoring pre-diabetes, or optimizing your metabolic health. This comparison helps clarify which CGM is best suited for different types of users, based on wear time, accuracy, features, and intended use.
| Device | Wear Time | Accuracy (MARD) | Alerts | Best For |
| Abbott FreeStyle Libre 3 | 14–15 days | ~8.9% | Yes (real-time) | Type 1 & 2 diabetics seeking affordability |
| Dexcom G7 (15-Day) | 15 days | ~8.0–8.2% | Yes (predictive) | Insulin users, pump users, tech-savvy patients |
| Senseonics Eversense 365 | 180–365 days | ~8.5% | Yes (vibrating alerts) | Users wanting long-term wear, minimal changes |
| Medtronic Guardian 3 | 7 days | ~8–10% | Yes (predictive) | Medtronic pump users needing full integration |
| Dexcom Stelo | 15 days | Comparable to G7 | No medical alerts | Wellness, pre-diabetics, non-insulin users |
| Abbott Lingo | 14 days | Moderate | Limited | Non-diabetics, metabolic tracking |
| Nutrisense Flux / Levels | 14–21 days | Moderate | Via app + coaching | Health optimizers, biohackers |
| Biolinq Smartpatch | ~30 days (projected) | Lower | No (early stage) | Needle-averse, wellness-focused users |
With a growing range of CGMs available in 2025, there's a solution for nearly every type of user. Whether you're managing a medical condition or simply aiming to improve your metabolic health, this guide helps match you to the device that fits your needs and lifestyle.
Understanding how CGMs perform in everyday life is just as important as their technical specs. Here’s a look at real-world feedback from users, highlighting both the strengths and challenges of today’s most popular continuous glucose monitors.
Many users praise the G7 for its reliability, especially its fast warm-up time and accurate alerts. Some report minor issues like occasional skin irritation or short-lived signal drops, but overall it’s seen as dependable and easy to integrate into daily routines.
While users appreciate the slim profile and low cost of the Libre 3, complaints about app instability and frequent sensor failures are common. Several users report sensors falling off early or failing to complete the full wear time, which can be frustrating during active lifestyles.
Eversense earns high marks from users who value long-term wear and dislike frequent sensor changes. However, the need for a minor surgical procedure to implant and remove the sensor can be a barrier for some, especially new users.
These wellness-focused CGMs are appreciated for offering easy access to real-time glucose data without a prescription. However, some users find the lack of clinical alerts and context confusing, leading to anxiety or over-interpretation of normal glucose fluctuations.
While CGMs offer powerful insights, user experiences show that no device is perfect. It’s important to consider not only features and specs but also how each CGM fits into your lifestyle, comfort level, and expectations for accuracy and reliability.
With the growing popularity of continuous glucose monitors, it's important to understand the difference between clinical and consumer use. Whether you're managing diabetes or simply curious about your glucose trends, choosing the right type of CGM ensures you get the right level of support and accuracy.
| Clinical-Grade CGMs | Consumer/Wellness CGMs |
| Designed for people with type 1 or type 2 diabetes, clinical-grade CGMs like Dexcom G7, Libre 3, and Eversense 365 offer medical-grade accuracy, real-time alerts, and integration with insulin pumps. These devices are prescription-only and approved for use in treatment decisions and insulin dosing. | Devices like Dexcom Stelo, Abbott Lingo, and Nutrisense Flux are tailored for general wellness, offering glucose trend data without medical alerts or insulin integration. They’re typically sold over-the-counter and are best suited for people exploring diet, fitness, or metabolic health—not for managing diabetes. |
Choosing between clinical and consumer CGMs comes down to your health goals. If you're treating a medical condition like diabetes, a clinical-grade CGM is essential; if you're looking for general insight into your metabolism, a wellness CGM may be enough. Always consult a healthcare provider before making your choice.
In 2025, continuous glucose monitors have evolved to serve a wide range of users—from those with diabetes needing clinical accuracy and real-time alerts, to wellness seekers tracking their metabolic health. Devices like the Dexcom G7, Abbott Libre 3, and Eversense 365 lead the way in prescription-grade monitoring, while consumer-focused options like Stelo, Lingo, and Nutrisense make glucose tracking more accessible than ever.
Whether you’re managing insulin therapy, preventing blood sugar spikes, or simply optimizing your lifestyle, there’s a CGM designed to fit your needs. By understanding how each device works, who it’s for, and real-world user experiences, you can make a more informed choice for better health and smarter glucose management.
